Skip to main content
Journal Guides2 min readUpdated Jun 18, 2026

Is PLOS ONE Indexed in PubMed? Yes, With Active MEDLINE Indexing

PLOS ONE is indexed in PubMed and currently indexed for MEDLINE, with coverage from volume 1, issue 1 in 2006 and PMC visibility also listed.

By Manusights Editorial Team•
Editorial processThe Manusights editorial team researches and maintains our Clinical Medicine & Public Health guides, drawing on what we see across thousands of pre-submission manuscript reviews.How we work

Next step

Choose the next useful decision step first.

Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.

Open Journal Fit ChecklistAnthropic Privacy Partner. Your manuscript is never used to train any model.Run Free Readiness Scan
Journal context

PLOS ONE at a glance

Key metrics to place the journal before deciding whether it fits your manuscript and career goals.

Full journal profile
Acceptance rate~31%Overall selectivity
Time to decision40 days medianFirst decision
Open access APC$1,931Gold OA option

What makes this journal worth targeting

  • PLOS ONE's scope and readership determine whether the journal is a useful target.
  • Scope specificity matters more than headline metrics for most manuscript decisions.
  • Acceptance rate of ~31% means fit determines most outcomes.

When to look elsewhere

  • When your paper sits at the edge of the journal's stated scope, borderline fit rarely improves after submission.
  • If timeline matters: PLOS ONE takes 40 days median. A faster-turnaround journal may suit a grant or job deadline better.
  • If OA is required: gold OA costs $1,931. Check institutional agreements before submitting.

Quick answer: yes. PLOS ONE is indexed in PubMed, currently indexed for MEDLINE, and also listed in PubMed Central from volume 1, issue 1 in 2006. That is the important discoverability fact.

The journal's high-volume, soundness-based model does not make it invisible or weakly indexed. A paper published there enters the normal biomedical search workflow cleanly, then benefits from full-text PMC access as well.

Direct answer

If you publish in PLOS ONE, the article is discoverable in PubMed and the journal remains inside the active MEDLINE system.

NLM field
What the record shows
Why it matters
publication start year
2006
the indexing story is tied to the title's launch
PubMed coverage
v1n1, 2006-
searchable from the first issue
MEDLINE coverage
v1n1, 2006-
the title is in the curated NLM journal index from launch
PMC listing
PMC
full-text open-access visibility is part of the journal's circulation model
current indexing status
Currently indexed for MEDLINE
active inclusion, not a historical leftover
current subset
Index Medicus
the title sits inside a standard biomedical indexing channel

That is a clean and unusually strong discoverability record for a large open-access journal.

Why this matters for PLOS ONE

Authors usually ask this question about PLOS ONE for a different reason than they ask it about top-selective journals. The concern is often not prestige. It is whether the journal is:

  • legitimate enough for formal biomedical indexing
  • discoverable enough for citations and downstream reuse
  • integrated enough into PubMed workflows to avoid disappearing after publication
  • visible enough to offset the journal's broad, soundness-first editorial model

The indexing answer is yes. Whatever debate you want to have about selectivity, PLOS ONE is not outside the biomedical literature system. It is fully inside it.

What the indexing record tells you in practice

Practical question
What the record tells you
will a published paper show up in normal PubMed searches?
yes
is the title actively indexed for MEDLINE?
yes
does coverage begin from the first issue?
yes
does the journal also have PMC visibility?
yes
does that prove the journal is the best venue for your paper?
no

That last answer matters because indexing and venue strategy are not the same question.

PubMed versus MEDLINE versus PMC for PLOS ONE

For PLOS ONE, all three signals matter:

  • PubMed means the article is discoverable in the main biomedical search interface.
  • MEDLINE means the title is part of the curated NLM journal index, not merely appearing through indirect deposit routes.
  • PubMed Central matters because PLOS ONE is a fully open-access journal and full-text availability is part of how its papers get reused, cited, and passed around.

That three-part combination is one reason PLOS ONE remains easy to discover despite its scale and broad scope.

How this compares with nearby journal models

Journal pattern
What indexing usually supports
What indexing does not settle
broad soundness journal like PLOS ONE
strong discoverability and archive access
prestige, selectivity, or journal-brand signaling
selective disciplinary journal
targeted audience plus strong search visibility
whether the paper should trade breadth for prestige
new or weakly indexed venue
search visibility may be uneven or delayed
whether the science itself is strong

This is why indexing is useful but limited. It tells you the paper will be findable. It does not tell you whether the venue is the right strategic move.

How to verify the record yourself

If you want to check the indexing manually:

  1. open the NLM Catalog record
  1. confirm the PubMed line
  1. confirm the MEDLINE line
  1. confirm the PMC listing
  1. check Current Indexing Status
  1. run a direct journal-title search in PubMed

For PLOS ONE, that manual check is useful because it removes a common misconception: the journal is broad and high-volume, but its indexing status is straightforward and fully established.

What we see in PubMed-Indexing Questions for PLOS ONE

For PubMed-indexing questions for PLOS ONE, three patterns show up repeatedly.

The legitimacy worry. Some authors ask this because they suspect a large, soundness-based OA journal may have weaker indexing than older selective titles. For PLOS ONE, that concern is usually misplaced. The title is in PubMed, in MEDLINE, and in PMC.

The indexing-equals-quality shortcut. Other authors solve the indexing question and then act as if that settles the submission question. It does not. A fully indexed journal can still be the wrong venue if your goals depend more on selective signaling than on broad discoverability.

The open-access confusion. Another common mistake is assuming PMC visibility alone is the same thing as full journal indexing. For PLOS ONE, the answer is stronger than that. The title has both launch-to-present MEDLINE coverage and PMC visibility.

That is the real information gain on this page. The indexing story is strong. The venue-choice story is separate.

What the NLM record means in practice for authors

The useful thing about the PLOS ONE record is how little ambiguity it leaves. Coverage starts from launch in 2006, MEDLINE status is active, and PMC is listed as well. There is no late-start caveat or archive-only explanation to decode.

For authors, that means discoverability after publication is not the thing to worry about. If you publish here, readers can find the work through PubMed, then often access the full text directly through PMC or the journal site.

The harder decision is whether PLOS ONE is the right editorial model for your goals. If you mainly want rigorous, searchable publication with broad access, the indexing record supports that. If you need a narrower disciplinary audience or stronger prestige filtering, that is a different call.

That distinction is why this page matters. It answers the legitimacy and discoverability question cleanly, then gets out of the way so you can make the more important venue decision on purpose.

What indexing does and does not tell you

This page answers the discoverability question. It does not answer whether PLOS ONE is the right submission strategy for your paper.

Indexing tells you:

  • the published paper will be visible in PubMed
  • the journal is actively indexed for MEDLINE
  • full-text circulation also benefits from PMC presence

Indexing does not tell you:

  • whether the soundness-first model matches your goals
  • whether a narrower specialty title would create better audience fit
  • whether prestige signaling matters more than breadth for this manuscript

That is why the better next reads are:

If the fit question is what you actually need answered, a PLOS ONE submission readiness check gives you a manuscript-specific signal before you submit.

Submit If / Think Twice If

Use this indexing answer as enough reassurance if:

  • your main concern is whether the paper will be easy to find after publication
  • you want confirmation that the journal is inside both PubMed and MEDLINE
  • open-access full-text availability is part of your dissemination goal

Think twice if:

  • you are using indexing as a proxy for journal quality or prestige
  • the manuscript may need a narrower field-specific audience
  • what you really need is a venue-strategy judgment, not a database-status answer

Readiness check

Run the scan while the topic is in front of you.

See score, top issues, and journal-fit signals before you submit.

Get free manuscript previewAnthropic Privacy Partner. Your manuscript is never used to train any model.See example reports

Practical verdict

Yes, PLOS ONE is indexed in PubMed and currently indexed for MEDLINE, with PMC visibility also listed from the journal's launch in 2006.

If your question is whether a published paper will be visible in the biomedical search and archive workflow, the answer is yes. If your real question is whether the journal's soundness-based model is the right strategic fit for your paper, that remains a separate call. A PLOS ONE submission readiness check is a direct way to pressure-test that decision before submission.

Frequently asked questions

Yes. PLOS ONE is indexed in PubMed and currently indexed for MEDLINE according to the NLM Catalog.

Yes. The NLM Catalog record also lists PubMed Central coverage.

Because authors often confuse a soundness-based, high-volume journal model with weak discoverability. PubMed and MEDLINE status show that PLOS ONE is fully integrated into the biomedical literature system.

Open the journal's NLM Catalog record, check the current indexing status plus the PubMed, MEDLINE, and PMC lines, and confirm recent papers appear normally in PubMed.

References

Sources

  1. 1. PLOS ONE NLM Catalog record, NLM.
  2. 2. NLM Catalog help: current indexing status, NLM.
  3. 3. PLOS ONE journal page, PLOS.
  4. 4. PLOS ONE submission guidelines, PLOS.
  5. 5. PLOS ONE in PubMed, PubMed.

Before you upload

Choose the next useful decision step first.

Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.

Use the scan once the manuscript and target journal are concrete enough to evaluate.

Anthropic Privacy Partner. Your manuscript is never used to train any model.

Open Journal Fit ChecklistRun Free Readiness Scan
Internal navigation

Where to go next

Start here

Same journal, next question

Supporting reads

Conversion step

Back to all articles